IN8bio Inc (INAB)

0.3126 -0.03 (-9.39%) USD  |  NASDAQ  |  Jan 08, 16:00
0.3181 +0.01 (+1.76%) After-Hours: 20:00
More

IN8bio Research and Development Expense (Annual): 16.83M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for INAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Genprex Inc 17.62M
Ensysce Biosciences Inc 7.588M
Biomarin Pharmaceutical Inc 746.77M
Arbutus Biopharma Corp 73.70M
GlycoMimetics Inc 20.07M